Keurig Dr Pepper (NYSE:KDP) was downgraded by equities researchers at Gabelli from a “buy” rating to a “hold” rating in a research note issued on Thursday, Marketbeat Ratings reports.
A number of other brokerages have also commented on KDP. Goldman Sachs Group began coverage on Keurig Dr Pepper in a report on Wednesday, July 18th. They issued a “neutral” rating and a $26.00 price objective on the stock. Susquehanna Bancshares began coverage on Keurig Dr Pepper in a report on Wednesday, July 25th. They issued a “positive” rating and a $33.00 price objective on the stock. Bank of America set a $30.00 price objective on Keurig Dr Pepper and gave the company a “buy” rating in a report on Monday, July 16th. ValuEngine lowered Keurig Dr Pepper from a “sell” rating to a “strong sell” rating in a report on Thursday, August 2nd. Finally, Guggenheim began coverage on Keurig Dr Pepper in a report on Thursday, September 13th. They issued a “neutral” rating and a $22.00 price objective on the stock. Nine equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Keurig Dr Pepper presently has an average rating of “Hold” and an average price target of $25.38.
Shares of NYSE KDP opened at $28.52 on Thursday. The company has a current ratio of 0.93, a quick ratio of 0.75 and a debt-to-equity ratio of 1.52. Keurig Dr Pepper has a one year low of $20.46 and a one year high of $126.65. The firm has a market capitalization of $38.37 billion, a price-to-earnings ratio of 6.28, a PEG ratio of 1.65 and a beta of 0.47.
In related news, insider Brian Andrew Loucks bought 13,050 shares of Keurig Dr Pepper stock in a transaction dated Thursday, September 6th. The shares were bought at an average cost of $22.86 per share, with a total value of $298,323.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Herbert Derek Hopkins bought 22,000 shares of Keurig Dr Pepper stock in a transaction dated Tuesday, August 28th. The shares were bought at an average cost of $22.94 per share, for a total transaction of $504,680.00. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 188,320 shares of company stock worth $4,399,673. 0.58% of the stock is currently owned by insiders.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Columbia Asset Management acquired a new stake in Keurig Dr Pepper in the third quarter valued at about $107,000. Whittier Trust Co. of Nevada Inc. acquired a new stake in Keurig Dr Pepper in the third quarter valued at about $116,000. Ledyard National Bank acquired a new stake in Keurig Dr Pepper in the third quarter valued at about $117,000. Harvest Fund Management Co. Ltd acquired a new stake in Keurig Dr Pepper in the third quarter valued at about $141,000. Finally, Ffcm LLC acquired a new stake in Keurig Dr Pepper in the third quarter valued at about $158,000. 11.56% of the stock is currently owned by institutional investors.
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc engages in the brewing system and specialty coffee businesses in the United States and Canada. The company sources, produces, and sells coffee, hot cocoa, teas, and other beverages in K-Cup, Vue, Rivo, K-Carafe, and K-Mug pods brands; coffee in traditional packaging, including bags and fractional packs; and other specialty beverages in pods.
See Also: Float
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.